Fate Therapeutics Inc (FATE)
2.375
-0.12
(-4.62%)
USD |
NASDAQ |
Oct 31, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Accounts Payable (Quarterly): 5.495M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 5.495M |
March 31, 2024 | 6.765M |
December 31, 2023 | 4.719M |
September 30, 2023 | 5.706M |
June 30, 2023 | 7.506M |
March 31, 2023 | 9.855M |
December 31, 2022 | 8.265M |
September 30, 2022 | 9.593M |
June 30, 2022 | 8.42M |
March 31, 2022 | 11.44M |
December 31, 2021 | 8.612M |
September 30, 2021 | 6.439M |
June 30, 2021 | 5.771M |
March 31, 2021 | 8.998M |
December 31, 2020 | 6.283M |
September 30, 2020 | 3.717M |
June 30, 2020 | 13.56M |
March 31, 2020 | 5.173M |
December 31, 2019 | 5.822M |
September 30, 2019 | 5.715M |
June 30, 2019 | 5.41M |
March 31, 2019 | 5.367M |
December 31, 2018 | 4.205M |
Date | Value |
---|---|
September 30, 2018 | 5.236M |
June 30, 2018 | 3.51M |
March 31, 2018 | 2.16M |
December 31, 2017 | 1.678M |
September 30, 2017 | 2.198M |
June 30, 2017 | 1.177M |
March 31, 2017 | 2.47M |
December 31, 2016 | 0.934M |
September 30, 2016 | 1.20M |
June 30, 2016 | 1.998M |
March 31, 2016 | 1.975M |
December 31, 2015 | 0.996M |
September 30, 2015 | 1.28M |
June 30, 2015 | 1.507M |
March 31, 2015 | 1.271M |
December 31, 2014 | 0.645M |
September 30, 2014 | 1.157M |
June 30, 2014 | 0.98M |
March 31, 2014 | 1.33M |
December 31, 2013 | 0.682M |
September 30, 2013 | |
June 30, 2013 | |
December 31, 2012 | 1.228M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.717M
Minimum
Sep 2020
13.56M
Maximum
Jun 2020
7.481M
Average
6.765M
Median
Mar 2024
Accounts Payable (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.235M |
Palatin Technologies Inc | 4.102M |
iBio Inc | 0.358M |
Theriva Biologics Inc | 0.935M |
Oragenics Inc | 1.180M |